Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: GOG Foundation
Condition: Advanced, Persistent, or Recurrent Endometrial Cancer
NCT02228681
Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.